首页> 美国卫生研究院文献>Journal of Diabetes Investigation >Dipeptidyl peptidase‐4 inhibitors‐associated bullous pemphigoid: A retrospective study of 168 pemphigoid and 9304 diabetes mellitus patients

【2h】

Dipeptidyl peptidase‐4 inhibitors‐associated bullous pemphigoid: A retrospective study of 168 pemphigoid and 9304 diabetes mellitus patients

机译：二肽基肽酶-4抑制剂相关的大疱性类天疱疮：168例天疱疮和9304例糖尿病患者的回顾性研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Aims/IntroductionBullous pemphigoid (BP) might be drug‐induced. The present study evaluated the relationship between BP and dipeptidyl peptidase‐4 inhibitors (DPP4Is).

机译：目的/简介牛类天疱疮（BP）可能是药物引起的。本研究评估了BP与二肽基肽酶-4抑制剂（DPP4Is）之间的关系。

著录项

期刊名称 Journal of Diabetes Investigation
作者
Yohei Kawaguchi; Risa Shimauchi; Nobuhiro Nishibori; Kiyohito Kawashima; So Oshitani; Atsushi Fujiya; Taiga Shibata; Norimi Ohashi; Kentaro Izumi; Wataru Nishie; Hiroshi Shimizu; Hiroshi Arima; Hiroshi Sobajima;
展开▼
作者单位

展开▼
年(卷),期 2019(10),2
年度 2019
页码 392–398
总页数 7
原文格式 PDF
正文语种
中图分类基础医学;
关键词
Bullous pemphigoid Dipeptidyl peptidase‐4 inhibitors Drug side‐effect;

机译：大疱性类天疱疮;二肽基肽酶-4抑制剂;药物副作用;

相似文献

外文文献
中文文献
专利

1. Dipeptidyl peptidase‐4 inhibitors‐associated bullous pemphigoid: A retrospective study of 168 pemphigoid and 9,304 diabetes mellitus patients [J] . Yohei Kawaguchi, Risa Shimauchi, Nobuhiro Nishibori, Journal of diabetes investigation. . 2019,第2期

机译：二肽基肽酶-4抑制剂相关的大疱性类天疱疮：168例天疱疮和9,304例糖尿病患者的回顾性研究
2. Reply to: "Comment on 'Oral diabetes medications other than dipeptidyl peptidase-4 inhibitors are not associated with bullous pemphigoid: A Finnish nationwide case-control study' and a case report of glucagon-like peptide-1 receptor agonist-induced bullous pemphigoid'' [J] . Varpuluoma Outi, Tasanen Kaisa, Huilaja Laura Journal of the American Academy of Dermatology . 2019,第6期

机译：回复：“评论除了二肽基肽酶-4抑制剂以外的口腔糖尿病药物与大疱性毒性的抑制剂无关：芬兰国家病例对照研究'以及胰高血糖素肽-1受体激动剂诱导的大疱病 '
3. Comment on "Oral diabetes medications other than dipeptidyl peptidase-4 inhibitors are not associated with bullous pemphigoid: A Finnish nationwide case-control study'' and a case report of glucagon-like peptide-1 receptor agonist-induced bullous pemphigoid [J] . Schwager Zachary, Mikailov Anar, Lipworth Adam D. Journal of the American Academy of Dermatology . 2019,第6期

机译：评论“除了二肽基肽酶-4抑制剂以外的口腔糖尿病药物与大疱性疱疹病毒（Dellous Pemphigoid）无关：芬兰国家病例对照研究”“和胰高血糖素肽-1受体激动剂诱导的大疱病毒诱导的大疱病
4. Predicting the onset of bullous pemphigoid with co-morbidities: A survey based on a nationwide medical database [C] . Chu-Cheng Kuo, Fang-Chi Yang, Meng-Han Yang, IEEE International Conference on Bioinformatics and Biomedicine . 2013

机译：预测并发大疱性天疱疮的发病率：基于全国医学数据库的一项调查
5. Structural and functional analysis of bullous pemphigoid antigen1 (BPAG1) [D] . Jefferson, Julius J. 2007

机译：大疱性类天疱疮抗原1（BPAG1）的结构和功能分析
6. A Cross-Sectional Study Comparing the Prevalence of Bullous Pemphigoid Autoantibodies in 275 Cases of Type II Diabetes Mellitus Treated With or Without Dipeptidyl Peptidase-IV Inhibitors [O] . Kentaro Izumi, Wataru Nishie, Mutsuo Beniko, -1

机译：一项横断面研究比较在接受或不接受二肽基肽酶-IV抑制剂治疗的275例II型糖尿病中大疱性类天疱疮自身抗体的发生率
7. Comment on “Oral diabetes medications other than dipeptidyl peptidase-4 inhibitors are not associated with bullous pemphigoid: A Finnish nationwide case-control study” and a case report of glucagon-like peptide-1 receptor agonist–induced bullous pemphigoid [O] . Zachary Schwager, Anar Mikailov, Adam D. Lipworth 2019

机译：评论“除了二肽基肽酶-4抑制剂以外的口腔糖尿病药物与大疱性毒性的情况无关：芬兰国家病例对照研究”和胰高血糖素肽-1受体激动剂诱导的大疱性大疱性Pemphigoid的病例报告

Dipeptidyl peptidase‐4 inhibitors‐associated bullous pemphigoid: A retrospective study of 168 pemphigoid and 9304 diabetes mellitus patients

摘要

著录项

相似文献

相关主题

期刊订阅